A patient has been on bupropion XL 300 mg daily for 20 years and sertraline (Zoloft) 125 mg initially then 100 mg for the past year and remains severely depressed; what medication should be added or used to augment treatment?

Treatment-Resistant Depression: Augmentation Strategy

For this patient with severe depression despite 20 years of bupropion XL 300mg and recent sertraline treatment, the most evidence-based approach is to augment the current SSRI (sertraline) with bupropion, as the patient is already on bupropion but may benefit from optimizing this combination strategy, or consider adding cognitive behavioral therapy (CBT) as augmentation.

Current Medication Assessment

The patient is already on a combination of:

• Bupropion XL 300mg (maximum dose for depression)
• Sertraline 100mg (reduced from 125mg)

This represents a dual-mechanism approach (norepinephrine/dopamine reuptake inhibition plus serotonin reuptake inhibition), but the response remains inadequate 1.

Evidence-Based Augmentation Options

Option 1: Optimize Current Combination Therapy

Increase sertraline dose back to 125mg or higher (up to 200mg maximum). The American College of Physicians guidelines indicate that if patients don't respond adequately within 6-8 weeks, treatment modification is warranted 1. The reduction from 125mg to 100mg may have contributed to treatment failure 1.

• Low-quality evidence shows augmentation of an SSRI with bupropion decreases depression severity more than augmentation with buspirone 1
• Moderate-quality evidence demonstrates discontinuation due to adverse events was lower with bupropion augmentation compared to buspirone 1
• The combination of bupropion and sertraline has demonstrated efficacy in treatment-refractory depression through synergistic effects on serotonergic, dopaminergic, and noradrenergic systems 2, 3

Option 2: Add Cognitive Behavioral Therapy

Augment pharmacotherapy with CBT. Low-quality evidence shows no difference in response, remission, or depression severity when augmenting an SSRI with another antidepressant versus augmenting with cognitive therapy 1.

• CBT as augmentation has similar efficacy to pharmacologic augmentation but with fewer adverse effects 1
• CBT may provide lower relapse rates compared to medication alone 1

Option 3: Switch Strategies

If augmentation fails, consider switching to a different second-generation antidepressant:

• Switch to venlafaxine (SNRI): Moderate-quality evidence shows no difference in response when switching from one second-generation antidepressant to another (bupropion vs. sertraline vs. venlafaxine) 1
• The combination of venlafaxine and bupropion has shown efficacy in treatment-resistant depression 4

Critical Safety Considerations

Drug Interactions to Monitor

Bupropion inhibits CYP2D6, which can increase sertraline levels 5. This interaction may require dose adjustment of sertraline, particularly given the patient's severe depression 5.

• Monitor for serotonin syndrome when combining serotonergic medications, though risk is lower without MAOIs 1
• Watch for symptoms within 24-48 hours after any dose changes: mental status changes, neuromuscular hyperactivity, autonomic hyperactivity 1

Seizure Risk

Bupropion at 300mg daily is at the threshold where seizure risk increases 5. Do not exceed 450mg/day of immediate-release or 400mg/day of sustained-release formulations 1, 5.

Monitoring Requirements

• Assess patient status, therapeutic response, and adverse effects within 1-2 weeks of any treatment modification 1
• Monitor for suicidal ideation, especially during the first 1-2 months of treatment changes 1
• Watch for agitation, irritability, or unusual behavioral changes 1

Recommended Treatment Algorithm

1. First-line approach: Increase sertraline back to 125mg or higher (up to 200mg maximum) while maintaining bupropion XL 300mg 1

2. If inadequate response after 6-8 weeks: Add CBT as augmentation to the medication regimen 1

3. If still inadequate response: Consider switching sertraline to venlafaxine while maintaining bupropion, or switch to a different combination entirely 1

4. Throughout treatment: Continue therapy for at least 4-9 months after achieving satisfactory response, with consideration for longer duration given the patient's chronic, severe presentation 1

Common Pitfalls to Avoid

• Don't prematurely discontinue effective medications: The patient has been on bupropion for 20 years, suggesting some benefit; complete discontinuation may worsen outcomes 1
• Don't combine with MAOIs: At least 14 days must elapse between MAOI discontinuation and bupropion initiation 5
• Don't ignore the sertraline dose reduction: The decrease from 125mg to 100mg may have precipitated the current severe depression 1
• Don't overlook non-pharmacologic options: CBT has comparable efficacy to medication augmentation with potentially fewer adverse effects 1